Northwest Hospital
Seattle, Washington 98133
0 studies enrolling now · 14 studies all time
What they study most
Alzheimer Disease, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Blood Component Transfusion, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Diabetes Mellitus, Type 2, Diabetic Foot Ulcer, Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma
Studies at this site
- Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers — Completed
- Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer — Completed
- Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer — Completed
- Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer — Completed
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer — Completed
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer — Status unconfirmed
- Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) — Completed
- Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Status unconfirmed
- Immunomodulation Following Transfusion — Completed
- Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
- Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed